Fresenius Medical Care AG (0H9X.IL)
| Previous close | 39.13 |
| Open | 38.97 |
| Bid | 38.74 x 0 |
| Ask | 39.71 x 0 |
| Day's range | 38.94 - 39.51 |
| 52-week range | 30.17 - 49.62 |
| Volume | |
| Avg. volume | 143,864 |
| Market cap | 14.214B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | 19.35 |
| EPS (TTM) | 2.03 |
| Earnings date | 30 Jul 2024 |
| Forward dividend & yield | 1.12 (3.38%) |
| Ex-dividend date | 17 May 2023 |
| 1y target est | N/A |
Simply Wall St.Fresenius Medical Care (ETR:FME) Will Be Hoping To Turn Its Returns On Capital Around
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
PR NewswireMoody's and S&P change Fresenius Medical Care's rating outlook to stable
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today received from S&P Global, a leading rating agency, the change of its rating outlook to stable from negative (bbb-, stable outlook). Moody's changed the credit rating outlook from negative to stable on May 17 (baa3, stable outlook).
- PR Newswire
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the presentation of nearly 40 company-affiliated research abstracts at the 61st European Renal Association (ERA) Congress, taking place May 23-26, 2024, in Stockholm, Sweden and virtually.
